Sign in

CIK 0001815442

  • Large accelerated filer

Kymera Therapeutics, Inc.

Sign in to watch
Ticker
KYMR
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
812992166
Phone
+1 857-285-5314
Business address
500 NORTH BEACON STREET, 4TH FLOOR, WATERTOWN, MA, 02472
Former names
Kymera Therapeutics, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$4,158,214
in 2 filings, $3.4M under 10b5-1 plans

Net −$4,158,214. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 68 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2022-11-01 Booth Bruce Director Sale −15,804 $30.57 $483K 1,050,584
2022-11-01 Booth Bruce Director Sale −3,727 $31.08 $116K 5,537,456
2022-11-01 Booth Bruce Director Sale −1,044 $31.08 $32K 1,049,540
2022-11-01 Atlas Venture Fund X, L.P. 10% owner Sale −56,455 $30.57 $1.7M 5,541,183
2022-11-01 Atlas Venture Fund X, L.P. 10% owner Sale −15,804 $30.57 $483K 1,050,584
2022-11-01 Atlas Venture Fund X, L.P. 10% owner Sale −3,727 $31.08 $116K 5,537,456
2022-11-01 Atlas Venture Fund X, L.P. 10% owner Sale −1,044 $31.08 $32K 1,049,540
2022-10-31 Booth Bruce Director Sale −94,239 $30.23 $2.8M 5,597,638
2022-10-31 Booth Bruce Director Sale −26,383 $30.23 $798K 1,066,388
2022-10-31 Atlas Venture Fund X, L.P. 10% owner Sale −94,239 $30.23 $2.8M 5,597,638
2022-10-31 Atlas Venture Fund X, L.P. 10% owner Sale −26,383 $30.23 $798K 1,066,388
2022-10-28 Booth Bruce Director Sale −71,135 $30.00 $2.1M 5,691,877
2022-10-28 Booth Bruce Director Sale −19,915 $30.00 $597K 1,092,771
2022-10-28 Atlas Venture Fund X, L.P. 10% owner Sale −71,135 $30.00 $2.1M 5,691,877
2022-10-28 Atlas Venture Fund X, L.P. 10% owner Sale −19,915 $30.00 $597K 1,092,771
2022-10-21 Jacobs Bruce N. Chief Financial Officer Exercise or conversion +10,000 $2.08 $21K 81,279
2022-10-21 Jacobs Bruce N. Chief Financial Officer Exercise or conversion · Stock Option (Right to Buy) −10,000 139,899
2022-10-17 Jacobs Bruce N. Chief Financial Officer Exercise or conversion +10,000 $2.08 $21K 71,279
2022-10-17 Jacobs Bruce N. Chief Financial Officer Exercise or conversion · Stock Option (Right to Buy) −10,000 149,899
2022-10-17 Mainolfi Nello Chief Executive Officer Exercise or conversion +32,056 $2.08 $67K 534,255

Page 36 of 41 · 810 trades